Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in kenya: a modelling study

HIGHLIGHTS

• who: Naomi R. Waterlow from the We determine the cost-effectiveness of vaccination scenarios by calculating median incremental cost-effectiveness ratios (ICERs) per DALY averted and median incremental net monetary benefits (INMBs) across all ten years for each vaccine scenario compared to the no vaccination scenarioThe most cost-effective scenario is the one with the lowest ICER value and the highest INMB value. In the absence of locally-determined cost-effectiveness thresholds for health interventions in Kenya, ICERs are evaluated against a WHO u2018best buy` threshold of $, per DALY averted in LMICs as well as cost-effectiveness . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.